Cheap buy-in. I like your chances of making a significant score here. I've been distracted by other holdings lately, but in my opinion, the market over-reacted today to this latest offering. Hard to lose at this level.
Speedy does not watch Oscars:
Stop the presses. We have a real story. Some forgettable guy in some forgettable city decides to tune out a forgettable event.
In the third person, no less.
Last few trading days, up nicely in the morning, then give it all back, plus more, in the afternoon. Looking for the stock to finish what it starts, as the trend seems to warrant.
Of course, overall, can't complain about a 3-point-plus pop in the last month, with more to come.
It's getting to the point where I think a number of you right-wingers actually get aroused when you hear "Benghazi" because you so very lamely cling to it as a way to cast aspersions on your hate target.
You don't seem as hardcore as some of the other "contributors" here, but surely you can see it's questionably relevant to dredge up presidents from many decades ago to make your argument. Bush, however, "served" immediately preceding the subject of your attacks. So what he did or didn't do is very relevant when you try to make a relative mountain out of a proverbial molehill with Obama re Benghazi. No deaths should be swept under the rug, so to speak, but for crying out loud, someone needs to keep your attacks in perspective.
If it turns out you are lying to get bi-partisan support, shouldn't that trump any support you may have gotten. I'll answer that. Heeellll, yes.
What's laughable yet telling here is how right-wingers appear to be hanging on to any hint of a scandal in a desperate attempt to taint Obama in any, every way possible while I'm guessing that most of them had lock-jaw when Cheney-Bush lied us into a war that wound up killing many thousands.
One had to presume that the price would fall today based on the $1.30 bar set by NLST for the shares. But it's great sign for the company's future, at least short term, that the shares are showing such buoyancy today.
For a day or two, anyway.
Those scared/concerned about dilution should not be in this situation, in my opinion. I've seen it be a significant plus with other cash-needy stocks, and I'm sensing it will be plus here. This company is positioning itself for an upward ride.
From the August 8 earnings report, Skim Vanaselja, the company's CFO, said BCE would be able to absorb the costs of the Astral acquisition in the second half of 2013, and added:
"We expect to begin realizing the full financial benefits of this acquisition in 2014 with strong free cash flow accretion to support our dividend growth objective."
The strong are getting stronger, with at least more dividend money in our pockets.
This nuthead48 appears to be truly a nuthead. Or maybe just a short. On Jan. 5 he said he was going to get out of BCE. On Jan. 18 he was still saying it. Either he's inexplicably slow on the trigger or is trying to rattle those still holding the stock, I.e. A short. Those still in BCE will be rewarded soon enough, when the fruits of the Astral merger really begin to kick in.
So, to follow your rationale, we should give up trying? The U.S. Remains the planet's biggest poluter, so what we do isn't insignificant.
You make an interesting accusation. Is this your suspicion or do you have verification?
From what I can see, you have as good a handle on what's happening with Netlist as anybody here. I have come to treat your posts with regard. Thanks.
For those who haven't read the release, the company will will change its name to Heron Therapeutics and its symbol to HRTX after 20 trading days. It will have just 15 million shares -- great for upward stock movement if its drug is approved -- and the drug candidate will henceforth be called Sustol.
On another front, still waiting for shares to be returned to my account.